CANLI
Yükleniyor Veriler getiriliyor…
/ Atıflar / Detay

Atıf Detayı

Kurum makalesi · Scopus üzerinden alınan atıf kaydı

Kurumun Atıf Alan Makalesi
Atıf Alan Yayın
Screening of in vitro antioxidant and enzyme inhibitory activities of different extracts from two uninvestigated wild plants: Centranthus longiflorus subsp. longiflorus and Cerinthe minor subsp. auriculata
European Journal of Integrative Medicine Cilt 8 ss. 286-292
Scopus Toplam 130 atıf DOI
Introduction The importance of plants products in traditional medicine has been recognized for some time. Two plants of Turkish origin, Centranthus longiflorus subsp. longiflorus and Cerinthe minor subsp. auriculata used as traditional Turkish medicine have remained uninvestigated for Alzheimer diseases and diabetes mellitus for their in vitro biological activity despite their use for sleep disorders. The antioxidant and enzyme inhibitory properties of these plants have not been reported. The aim of this study was to determine the total phenolics, flavonoids, and antioxidant as well as their enzyme inhibitory activity (in aqueous and solvent extracts). Methods Antioxidant assays used standard methods to assess phosphomolybdenum, free radical scavenging activity, reducing power, and metal chelating activity on ferrous ions. Additionally, the extracts were tested also for enzyme inhibitory activity (Cholinesterase, Tyrosinase, α-amylase, and α-glucosidase). Results Organic extracts showed the highest anti-cholinesterase (AChE, and BChE) activity, while aqueous extracts showed valuable Tyrosinase inhibitory activity. Total phenolics (expressed as gallic acid equivalents) in C. longiflorus subsp. longiflorus and C. minor subsp. auriculata were 46.2 and 25.4 mg in methanolic extracts, 27.5 and 26.2 mg in ethyl acetate extracts, and 37.9 and 46.6 mg in aqueous extracts, respectively. Similarly, total flavonoids (expressed as rutin equivalents) in C. longiflorus subsp. longiflorus and C. minor subsp. auriculata were 39.9 and 27.8 mg in methanolic extracts, 17.6 and 52.4 mg in ethyl acetate extracts, and 24.35 and 24.6 mg in aqueous extracts, respectively. Conclusion The reported results may be valuable for preparing new food supplements and can represent a good model for the development of new drug formulations.
Atıf Kaynağı
Atıf Yapan Yayın
Antennaria dioica (L.) Gaertn. (Asteraceae): From Metabolite Profiling to Comprehensive Evaluation of In Vitro and In Silico Enzyme Inhibitory Activity
Food Science and Nutrition Cilt 14
Scopus Havuzumuzda Open Access
Antennaria dioica (L.) Gaertn., (tribe Gnaphalieae of Asteraceae family) is known in traditional medicine for treatment of biliary and respiratory ailments, and for its astringent and hemostatic properties. This work aimed at in-depth phytochemical profiling and in vitro antioxidant and enzyme inhibition assessment of methanol-aqueous extract from the A. dioica aerial parts integrated with molecular docking study. An ultra-high-performance liquid chromatography coupled to high resolution tandem mass spectrometry (UHPLC-HRMS/MS) analysis revealed a total of 130 secondary metabolites including 39 acylquinic acids, 26 caffeoylhexaric acids, 34 carboxylic and phenolic acids and coumarins, as well as 31 flavonoids. For the first time, 68 core structures alongside caffeoylglucaric derivatives leontopodic acid A and B are reported in the species. The A. dioica extract inhibited α-amylase and α-glucosidase (0.45 mmol and 0.11 mmol ACAE/g, respectively), and acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) (1.93 and 1.14 mmol Galantamine equivalent per gram extract (GALE/g), respectively). The extract exhibited antioxidant activity in different in vitro assays. In search for bioactive compounds, the extract's identified molecules were docked within four target enzymes: AChE (PDB code 4EY7), BChE (PDB code 7AMZ), α-amylase (PDB code 1Z32), and α-glucosidase (PDB code 5NN6). Twenty three core structures showed favorable docking scores for α-amylase and α-glucosidase, while only 4 of them were relevant for AChE and BChE. Methylbutyryl- and p-hydroxybenzoyl-tricaffeoylglucaric acid alongside apigenin 7-O-caffeoylglucoside were highlighted to contain potential ligands of α-amylase and α-glucosidase. The Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADME/Tox) properties of the selected compounds were evaluated in silico. Apigenin 7-O-caffeoyl-β-glucoside was outlined as having good potential for interaction with α-amylase and α-glucosidase, and favorable ADME/Tox properties.
Atıf Yapan Makale Bilgileri
Kurumlar (4)
Acibadem City Clinic Tokuda Hospital Sofia, Bulgaria
Institute of Biophysics and Biomedical Engineering, Bulgarian Academy of Sciences Sofia, Bulgaria
Medical University of Sofia Sofia, Bulgaria
Selçuk Üniversitesi Selçuklu, Turkey